Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$385M |
| 2 |
Microsoft
MSFT
|
+$368M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$298M |
| 4 |
Delta Air Lines
DAL
|
+$208M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$203M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.34B |
| 2 |
Tesla
TSLA
|
+$353M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$303M |
| 4 |
NVIDIA
NVDA
|
+$290M |
| 5 |
Boeing
BA
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.27% |
| 2 | Healthcare | 18.47% |
| 3 | Consumer Discretionary | 12.34% |
| 4 | Consumer Staples | 10.13% |
| 5 | Industrials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
Evolus
EOLS
$407M
| $154K | ﹤0.01% |
16,900
-146,000
| -90% | -$1.31M |
|
3152
Gain Therapeutics
GANX
$76.8M
| $154K | ﹤0.01% |
46,900
-700
| -1% | -$2.65K |
|
|
VIRX
3153
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $154K | ﹤0.01% |
148,199
+13,400
| +10% | +$18.2K |
|
3154
GDS Holdings
GDS
$6.55B
| $153K | ﹤0.01% |
14,000
-3,000
| -18% | -$34.3K |
|
3155
Data Storage Corp
DTST
$7.39M
| $150K | ﹤0.01% |
46,258
-4,143
| -8% | -$12.1K |
|
3156
American Shared Hospital Services
AMS
$9.87M
| $148K | ﹤0.01% |
59,988
-14,807
| -20% | -$38.6K |
|
3157
Creative Realities
CREX
$39.9M
| $148K | ﹤0.01% |
95,503
+13,300
| +16% | +$33.5K |
|
3158
Daxor
DXR
$61.2M
| $148K | ﹤0.01% |
15,821
+500
| +3% | +$4.85K |
|
|
DMRA
3159
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.9B
| $148K | ﹤0.01% |
8,204
+1,570
| +24% | +$61.6K |
|
|
STRR
3160
DELISTED
Star Equity Holdings
STRR
| $148K | ﹤0.01% |
30,300
+16,426
| +118% | +$83.4K |
|
3161
Trevi Therapeutics
TRVI
$2.65B
| $147K | ﹤0.01% |
67,300
-22,000
| -25% | -$49.7K |
|
3162
Biote Corp
BTMD
$68.5M
| $146K | ﹤0.01% |
28,577
-41,844
| -59% | -$247K |
|
3163
Capricor Therapeutics
CAPR
$228M
| $146K | ﹤0.01% |
42,621
-3,800
| -8% | -$21.4K |
|
|
SNCE
3164
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
| $146K | ﹤0.01% |
18,279
-13,986
| -43% | -$83.1K |
|
|
CMCT
3165
Creative Media & Community Trust
CMCT
$13.2M
| $145K | ﹤0.01% |
1
-1
| -50% | -$108K |
|
3166
Crexendo
CXDO
$215M
| $145K | ﹤0.01% |
68,704
+9,004
| +15% | +$16.5K |
|
|
JFIN
3167
Jiayin Group
JFIN
$145M
| $143K | ﹤0.01% |
+26,600
| New | +$151K |
|
|
HLTH
3168
DELISTED
Cue Health Inc. Common Stock
HLTH
| $143K | ﹤0.01% |
323,800
-61,100
| -16% | -$27.9K |
|
3169
Fathom Holdings
FTHM
$24.5M
| $142K | ﹤0.01% |
34,700
-200
| -0.6% | -$1.3K |
|
3170
Beyond Air
XAIR
$4.1M
| $142K | ﹤0.01% |
+154
| New | +$202K |
|
3171
Katapult Holdings
KPLT
$30.2M
| $141K | ﹤0.01% |
13,797
+161
| +1% | +$2.56K |
|
|
RENT
3172
Rent the Runway
RENT
$119M
| $141K | ﹤0.01% |
10,390
-325
| -3% | -$9.26K |
|
3173
Scienjoy Holding
SJ
$42M
| $141K | ﹤0.01% |
50,300
-9,400
| -16% | -$28.7K |
|
3174
Atomera
ATOM
$203M
| $140K | ﹤0.01% |
+22,400
| New | +$160K |
|
3175
Turkcell
TKC
$4.73B
| $139K | ﹤0.01% |
29,300
-114,956
| -80% | -$548K |
|
Similar funds
Renaissance Technologies's Q3 2023 Portfolio in Review
As of Q3 2023, Renaissance Technologies held 4,329 positions worth $58.7B, down 15% from $69.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $8.34B in Q3 2023, closing 714 positions and reducing 1,794 holdings. Its most notable exit was Chevron, an estimated $185M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in D.R. Horton worth $125M.
- Renaissance Technologies's largest Q3 2023 buy was D.R. Horton: 1,159,438 shares worth $125M.
- Renaissance Technologies added most to Netflix in Q3 2023, an estimated $385M increase.
- Renaissance Technologies's biggest Q3 2023 reduction was Meta Platforms (Facebook), cutting an estimated $1.34B.
- Renaissance Technologies fully exited Chevron in Q3 2023, selling an estimated $185M.
- Renaissance Technologies's ten largest holdings make up 12% of its $58.7B portfolio in Q3 2023.
- Renaissance Technologies opened 464 new positions and closed 714 in Q3 2023.
- Renaissance Technologies's portfolio value fell 15% quarter-over-quarter to $58.7B.
Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.